Skip to main navigation Skip to search Skip to main content

Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels

  • E. Gotuzzo
  • , B. Butron
  • , C. Seas
  • , M. Penny
  • , R. Ruiz
  • , G. Losonsky
  • , C. F. Lanata
  • , S. S. Wasserman
  • , E. Salazar
  • , J. B. Kaper
  • , S. Cryz
  • , M. M. Levine
  • Universidad Peruana Cayetano Heredia

Research output: Contribution to journalComment/debate

106 Scopus citations

Abstract

Groups of 122 Peruvian adults of low socioeconomic level (SEL) and 125 of high SEL received a randomly allocated 5 x 109- or 5 x 108-CFU dose of CVD 103-HgR live oral cholera vaccine or a placebo. The vaccine was well tolerated. Vibriocidal seroconversions occurred in 78% of high-SEL and 72% of low-SEL subjects who ingested the high dose and in 78 and 49%, respectively, of those who received the low dose.

Original languageEnglish
Pages (from-to)3994-3997
Number of pages4
JournalInfection and Immunity
Volume61
Issue number9
StatePublished - 1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels'. Together they form a unique fingerprint.

Cite this